Answers are grounded in this paper and cite their sources.
Diverse neuromuscular disorders can complicate the course of a severely ill patient. Critical illness polyneuropathy (CIP) is the most precisely defined neuromuscular complication in this context. It is characterized by a primary axonal degeneration of the motor and sensory nerve fibers with degeneration of the skeletal muscles as a result of their denervation. The precise etiology of CIP remains elusive. Electrophysiology must be used to confirm the diagnosis of CIP because clinical evaluation is clearly insufficient and testing can also exclude other entities such as a Guillain-Barré syndrome or a primary disorder of neuromuscular transmission. Nerve biopsy studies are not required for a diagnosis of CIP. Other disorders can explain neurophysiological abnormalities in critically ill patients after the use of neuromuscular blocking agents, such as persistent neuromuscular junction blockade, pure axonal neuropathy, and necrotizing myopathy. The incidence of myopathies in critically ill patients is not well characterized, although the incidence most likely is high in critically ill patients with prolonged stay in the intensive care unit (ICU). The clinical picture of a primary myopathy is indistinguishable from other ICU-acquired causes of neuromuscular disease. Three main forms of myopathies in the ICU have been described: critical illness myopathy, thick filament myopathy, and necrotizing myopathy. Myopathies are difficult to detect because the neurophysiological studies are neither sensitive nor specific and a muscle biopsy is required.
No takes yet. Share an insight, caveat, or question.
Garnacho‐Montero et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: